MedTrace Logo

Clinical Trial to Evaluate the Efficacy of Neuromuscular Electrical Stimulation Therapy in Patients With Sarcopenia

NCT07668258 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-06-25

No results posted yet for this study

Summary

The goal of this clinical trial is to exploratorily evaluate the safety and efficacy of a home-based lower extremity muscle strengthening and physical performance enhancement program using Neuromuscular Electrical Stimulation (NMES) devices.

Participants will apply NMES stimulation to both thighs for 8 weeks, at a frequency of at least 4 times per week.

Conditions

Interventions

DEVICE

neuromuscular electrical stimulation

once daily, for at least 20 minutes per session, at least 4 times per week, over the 8-week study period

Sponsors & Collaborators

  • The Catholic University of Korea

    collaborator OTHER

  • Exosystems

    lead INDUSTRY

Principal Investigators

  • Sangui Choi, CPO · Exosystems

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-09
Primary Completion
2026-12-31
Completion
2027-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07668258 on ClinicalTrials.gov